Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 0.49% | 14.42 | 14.2% | $227.85m | |
| SHPG | Shire PLC Sponsored ADR | -0.22% | 142.84 | 0.4% | $213.78m | |
| PRGO | Perrigo Co. Plc | -1.49% | 77.43 | 6.4% | $150.76m | |
| MNK | Mallinckrodt Plc | 0.22% | 37.20 | 17.7% | $117.37m | |
| UTHR | United Therapeutics Corporation | -0.43% | 130.72 | 13.9% | $87.52m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.16% | 146.50 | 2.2% | $80.04m | |
| ENDP | Endo International Plc | -0.48% | 8.34 | 8.9% | $70.27m | |
| HZNP | Horizon Pharma plc | -1.45% | 12.93 | 7.6% | $64.54m | |
| ALR | Alere Inc. | -0.35% | 49.39 | 2.7% | $63.82m | |
| PRXL | PAREXEL International Corporation | -0.08% | 87.66 | 7.9% | $62.65m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.14% | 106.94 | 22.1% | $62.05m | |
| MYOK | MyoKardia, Inc. | 0.80% | 44.15 | 3.0% | $54.03m | |
| MDCO | Medicines Company | 1.92% | 36.09 | 22.3% | $43.38m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.59% | 56.28 | 8.9% | $42.36m | |
| ICLR | ICON Plc | -1.03% | 106.78 | 4.2% | $41.60m |
Company Profile
Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs, and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.